Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia

Thalidomide for the Treatment of Thrombocytopenia and Hypersplenism in Patients With Cirrhosis or Thalassemia

Hypersplenism and thrombocytopenia are common complications of liver cirrhosis or thalassemia, but current treatment strategies are limited. This study aimed to evaluate the efficacy and safety of thalidomide in the treatment of hypersplenism and thrombocytopenia in patients with liver cirrhosis or...

Full description

Bibliographic Details
Main Authors: Yaocheng Chen, Ning Cai, Yongrong Lai, Weiwei Xu, Jinyan Li, Lan Huang, Ying Huang, Meiling Hu, Huangju Yang, Jiangming Chen
Format: Article
Language:English
Published: Frontiers Media S.A. 2020-07-01
Series:Frontiers in Pharmacology
Subjects:
thalidomide
thrombocytopenia
hypersplenism
thalassemia
liver cirrhosis
Online Access:https://www.frontiersin.org/article/10.3389/fphar.2020.01137/full

Internet

https://www.frontiersin.org/article/10.3389/fphar.2020.01137/full

Similar Items